How much credit should James Talarico receive for Texas’s $25 insulin copay cap?
James Talarico says he capped Texas insulin costs at $25 a month. Lois Kolkhorst says she authored the 2021 law. Records document Talarico’s earlier bill and House sponsorship, making this a dispute over legislative credit.
Case period:
Published by The Dispute Index editorial teamPublished Updated
Overview
S.B. 827’s enrolled version limits an enrollee’s cost sharing for a covered formulary insulin prescription to $25 per 30-day supply under specified health benefit plans; it is not a universal retail-price ceiling. The official bill history lists Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. Talarico’s H.B. 40, filed in November 2020, proposed a $100 monthly cap but did not advance out of committee. S.B. 827 began with a $50 cap and changed to $25 in a House committee report; the official record reviewed does not attribute that revision to a named individual. S.B. 827 was signed June 14, 2021, and took effect September 1, 2021. Its changes apply to covered plans delivered, issued for delivery, or renewed on or after January 1, 2022.
Talarico’s January 2026 campaign advertisement says he “took on Big Pharma and capped insulin at $25 a month.” Kolkhorst replied that he did not author the bill that passed in 2021. In May 2021 House remarks, Talarico called the legislation a team effort and named Kolkhorst, Lucio, and Oliverson. The record documents distinct roles in a shared legislative effort, without establishing a single objective allocation of all political credit.
People in this case
James TalaricoDirectly involved
Lois KolkhorstDirectly involved
Timeline
18 timeline entries on this page. Dates: November 9, 2020 to January 27, 2026
November 2020
James Talarico files H.B. 40
Talarico filed H.B. 40, an insulin-cap proposal that set a $100 maximum per 30-day supply in its introduced text and later remained pending in committee.
[01]H.B. 40 — 87th Texas Legislature bill history
Source excerpt
Relating to a cap on the monthly price of insulin and insulin supplies.
Official legislative history for Talarico’s H.B. 40. It establishes that he was an author of an earlier insulin-cap proposal and that the bill remained pending in committee rather than becoming the enacted $25 cost-sharing law.
H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021[02]H.B. 40 — introduced bill text
Source excerpt
Not to exceed one hundred dollars per thirty-day supply of insulin.
Talarico's introduced H.B. 40 proposed a $100 limit per 30-day supply and other provisions. It shows he advanced an earlier insulin-cap proposal, but it was not the enacted S.B. 827 text.
H.B. 40 — introduced bill text§ 1358.058(2), introduced version
February 2021
Talarico thanks Kolkhorst for meeting and offers to work on insulin
The Texas Tribune reports a February 5 text in which Talarico thanks Kolkhorst for their meeting the day before and says he looks forward to working with her on insulin.
[03]Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial
Source excerpt
But it was not his bill that passed. His bill died in committee.
The Tribune directly quotes Oliverson acknowledging Talarico's time and political capital advocating insulin caps, while describing his role in SB 827 as more ceremonial and giving Kolkhorst most credit. January 27 is the reporting date; the interview's exact date is not supplied.
Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial“Instrumental or ceremonial?” section; Oliverson’s directly attributed interview responseLois Kolkhorst files S.B. 827
Kolkhorst filed S.B. 827, which proposed a $50 insulin cost-sharing cap in its introduced version.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history[05]S.B. 827 — introduced bill text
Source excerpt
The enrollee is required to pay exceeds $50 for a 30-day supply.
The introduced version of S.B. 827 names Kolkhorst and proposed a $50 cost-sharing limit. It establishes the bill's initial text, not who later shaped every revision.
S.B. 827 — introduced bill text§ 1358.103(b), introduced version
March 2021
Senate committee hears S.B. 827
The Health and Human Services Committee considers Kolkhorst's insulin bill in a public hearing and takes testimony.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyTexas Senate passes S.B. 827
Kolkhorst's bill passes the Senate. The House receives it on March 29.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
April 2021
Talarico and Price present H.B. 40 at a news conference
The Texas Tribune describes the joint appearance. Talarico says Kolkhorst had planned to attend but was presenting another bill.
[03]Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial
Source excerpt
But it was not his bill that passed. His bill died in committee.
The Tribune directly quotes Oliverson acknowledging Talarico's time and political capital advocating insulin caps, while describing his role in SB 827 as more ceremonial and giving Kolkhorst most credit. January 27 is the reporting date; the interview's exact date is not supplied.
Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial“Instrumental or ceremonial?” section; Oliverson’s directly attributed interview responseHouse committee hears H.B. 40 and leaves it pending
The Insurance Committee takes testimony on Talarico's bill. Its history records no later committee action.
[01]H.B. 40 — 87th Texas Legislature bill history
Source excerpt
Relating to a cap on the monthly price of insulin and insulin supplies.
Official legislative history for Talarico’s H.B. 40. It establishes that he was an author of an earlier insulin-cap proposal and that the bill remained pending in committee rather than becoming the enacted $25 cost-sharing law.
H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021House committee begins considering a substitute for S.B. 827
The Insurance Committee takes testimony and leaves the substitute pending. It reports the bill favorably a week later.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyHouse committee reports substituted S.B. 827
The House Insurance Committee reported a substitute for S.B. 827 that contained the eventual $25 insulin cost-sharing limit; the official record does not assign the change to an individual.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history[06]S.B. 827 — House committee report bill text
Source excerpt
The enrollee is required to pay exceeds $25 per prescription for a 30-day supply.
The House committee report version of S.B. 827 contains the $25 cost-sharing limit enacted later. The document does not assign the revision to a particular individual.
S.B. 827 — House committee report bill text§ 1358.103(b), House committee report version
May 2021
Talarico reports work to move S.B. 827 through Calendars
The Texas Tribune reports a May 19 text in which Talarico tells Kolkhorst that work is underway to move S.B. 827 through Calendars and that he hopes it will reach the House floor the next week.
[03]Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial
Source excerpt
But it was not his bill that passed. His bill died in committee.
The Tribune directly quotes Oliverson acknowledging Talarico's time and political capital advocating insulin caps, while describing his role in SB 827 as more ceremonial and giving Kolkhorst most credit. January 27 is the reporting date; the interview's exact date is not supplied.
Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial“Instrumental or ceremonial?” section; Oliverson’s directly attributed interview responseTexas House passes amended S.B. 827
The Texas House passed S.B. 827 with the $25 cost-sharing provision. During floor remarks, Talarico described the legislation as a team effort.
[07]S.B. 827 — enrolled Texas bill text
Source excerpt
A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply.
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage[08]Texas House Journal — May 24, 2021, S.B. 827 remarks
Source excerpt
This legislation has been a team effort.
In official House-floor remarks on S.B. 827, Talarico described the effort as collaborative and thanked Lucio, Kolkhorst, and Oliverson. The journal preserves his contemporaneous characterization of roles, rather than independently resolving every participant's contribution.
Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 30 (printed p. 3794), S.B. 827 — RemarksTexas Senate concurs in the House amendment to S.B. 827
The Senate concurred in the House amendment containing the $25 insulin cost-sharing cap, completing legislative passage.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history[07]S.B. 827 — enrolled Texas bill text
Source excerpt
A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply.
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
June 2021
Governor Greg Abbott signs S.B. 827
Abbott signed S.B. 827, enacting the insulin cost-sharing law.
[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
September 2021
S.B. 827 takes legal effect
The statute took effect September 1, 2021. Its cost-sharing changes apply to covered plans delivered, issued for delivery, or renewed on or after January 1, 2022.
[07]S.B. 827 — enrolled Texas bill text
Source excerpt
A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply.
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
January 2022
Newly issued or renewed covered plans become subject to the insulin cap
S.B. 827’s changes apply to covered health benefit plans delivered, issued for delivery, or renewed from this date. Plans issued or renewed earlier remain governed by prior law for that purpose.
[07]S.B. 827 — enrolled Texas bill text
Source excerpt
A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply.
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
January 2026
Talarico campaign advertisement claims credit for $25 cap
Claim
A Talarico Senate-campaign advertisement says that he capped insulin at $25 a month while serving in the Texas House.
[09]“Insulin” — Talarico for TX Senate campaign advertisement
Source excerpt
So when I got to the Texas House, I took on Big Pharma and capped insulin at $25 a month.
Thirty-second campaign advertisement. The cited line follows Talarico’s account of his Type 1 diabetes diagnosis and a $684 insulin prescription. The ad claims he helped achieve the cap but does not expressly say he was the sole author of the enacted legislation.
“Insulin” — Talarico for TX Senate campaign advertisement00:00:15–00:00:20Kolkhorst disputes Talarico’s authorship of S.B. 827
Reaction
Kolkhorst responds that Talarico did not author the bill that passed in 2021 and says she authored S.B. 827.
[10]Lois Kolkhorst on authorship of Texas Senate Bill 827
Source excerpt
The truth is that you did not author the bill that passed in 2021.
Kolkhorst’s direct response to Talarico’s January 2026 insulin advertisement. She identifies herself as the filer and author of SB 827; the post addresses formal bill authorship.
Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758[04]S.B. 827 — 87th Texas Legislature bill history
Source excerpt
Author: Kolkhorst … Sponsor: Lucio III | Talarico.
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyTalarico campaign responds to authorship dispute
Reaction
A campaign spokesperson says Talarico was instrumental to S.B. 827’s passage and disputes claims that his role was not instrumental.
[11]New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costs
Source excerpt
Any assertion that he wasn’t instrumental to passing this bill is a flat-out lie.
The Texas Tribune reports a statement from Talarico campaign spokesperson JT Ennis, as well as competing accounts of the bill's development.
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costsCampaign spokesperson statement; legislative-record reporting
Claims
Claims separate what was said from what is contested. Follow each source for the original wording and context.
What was said
Attributed statement
James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Sources (2)
- “Insulin” — Talarico for TX Senate campaign advertisement00:00:15–00:00:20
- S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Attributed statement
Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Sources (2)
- Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
What's disputed
Disputed claim
Talarico for Texas
Talarico’s campaign says he introduced an earlier insulin-cap proposal, built bipartisan support, and was instrumental in S.B. 827’s passage.
Sources (4)
- New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costsCampaign spokesperson statement; legislative-record reporting
- H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
- Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 30 (printed p. 3794), S.B. 827 — Remarks
Arguments
Editorial analysis
Talarico’s documented role supports qualified credit
The official record shows that Talarico filed H.B. 40 before S.B. 827, served as a House sponsor of S.B. 827, and described the final effort as a team effort. Those facts support describing him as a participant in the legislative and advocacy effort that produced the cap.
Limit of this argument
They do not show that he was the formal author of S.B. 827 or that he authored the $25 amount.
Read sources and related claim
Related claim
James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Sources
- H.B. 40 — 87th Texas Legislature bill historyHistory page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
- Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 30 (printed p. 3794), S.B. 827 — Remarks
Editorial analysis
Kolkhorst’s formal authorship is documented
The official S.B. 827 history identifies Kolkhorst as the Senate author, while it identifies Lucio III and Talarico as House sponsors. The bill’s enacted $25 provision appears in the House committee report and enrolled text.
Limit of this argument
Formal authorship does not by itself measure every legislator’s advocacy, coalition-building, or political contribution to passage.
Read sources and related claim
Related claim
Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Sources
- Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758
- S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action history
- S.B. 827 — House committee report bill text§ 1358.103(b), House committee report version
- S.B. 827 — enrolled Texas bill text§ 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Response record
Responses
Choose one response filter, or select All responses to see the full record.
2 matching responses. Newest first.
Lois KolkhorstTexas state senatorDirectly involvedBefore this statement
Talarico’s Senate-campaign advertisement said that he had capped insulin at $25 a month.
"The truth is that you did not author the bill that passed in 2021."
Challenged the characterizationResponding to: Lois Kolkhorst says James Talarico did not author the 2021 S.B. 827 that established the $25 insulin cost-sharing cap.
Full statement and sources
Kolkhorst said Talarico did not author the enacted 2021 bill and identified herself as S.B. 827’s author.
After the statement
The official legislative history lists Kolkhorst as the Senate author and Talarico as a House sponsor, leaving broader credit for advocacy and collaboration contested.
Lois Kolkhorst on authorship of Texas Senate Bill 827Post ID 2014797717151555758S.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyWhy this label?
Kolkhorst challenges how Talarico’s campaign claim characterizes his formal role in the enacted legislation.
This label describes the statement's response within the context above.
James TalaricoTexas state representativeDirectly involvedBefore this statement
The Texas House was considering the Senate bill that would become the state’s insulin cost-sharing law.
"This legislation has been a team effort."
Mixed or conditionalResponding to: James Talarico says he capped insulin at $25 a month while serving in the Texas House.
Full statement and sources
During 2021 House-floor remarks on S.B. 827, Talarico described the insulin legislation as a team effort and named other lawmakers involved.
After the statement
Talarico thanked Lucio, Kolkhorst, and Oliverson, and said several lawmakers had filed similar bills on the subject.
Texas House Journal — May 24, 2021, S.B. 827 remarksPDF p. 30 (printed p. 3794), S.B. 827 — RemarksS.B. 827 — 87th Texas Legislature bill history87(R) SB 827; author and sponsor fields; action historyWhy this label?
The remark describes a shared account of legislative credit. It does not condemn or defend any person’s conduct.
This label describes the statement's response within the context above.
Sources
(17)
Original video
“Insulin” — Talarico for TX Senate campaign advertisement
Excerpt
"So when I got to the Texas House, I took on Big Pharma and capped insulin at $25 a month."
About this source
Thirty-second campaign advertisement. The cited line follows Talarico’s account of his Type 1 diabetes diagnosis and a $684 insulin prescription. The ad claims he helped achieve the cap but does not expressly say he was the sole author of the enacted legislation.
- Author
- James Talarico / Talarico for TX Senate
- Published
- Accessed
Original text
Dan Harmon defends Talarico’s insulin-cap credit as a bipartisan accomplishment
Relevant passage: Signed letter “Talarico is bipartisan”
Excerpt
"That’s hardly just voting yes for a bill."
About this source
Harmon responds to a prior letter challenging Talarico's credit and argues that the insulin cap reflects meaningful bipartisan work. He describes HB 40 as proposing $50; the official introduced text proposed $100. The letter's position and that documentary distinction are preserved separately.
- Author
- Dan Harmon
- Published
- Accessed
Original text
Steven Grover challenges Talarico’s campaign claims of legislative leadership
Relevant passage: Signed letter “Talarico ads lack honesty”
Excerpt
"Supporting good legislation deserves recognition."
About this source
Grover's signed letter disputes Talarico campaign credit for property-tax relief and insulin copays, distinguishing support from leadership. It is the letter writer's position, published by the San Antonio Express-News.
- Author
- Steven Grover
- Published
- Accessed
Interview
Tom Oliverson describes Talarico’s insulin-cap role as more ceremonial
Relevant passage: “Instrumental or ceremonial?” section; Oliverson’s directly attributed interview response
Excerpt
"But it was not his bill that passed. His bill died in committee."
About this source
The Tribune directly quotes Oliverson acknowledging Talarico's time and political capital advocating insulin caps, while describing his role in SB 827 as more ceremonial and giving Kolkhorst most credit. January 27 is the reporting date; the interview's exact date is not supplied.
- Author
- Kayla Guo; quoted interviewee Tom Oliverson
- Published
- Accessed
Original post
André Treiber defends shared legislative-credit conventions
Excerpt
"EVERYONE says “my bill passed” even when it’s the companion, omnibus, or whatever that made it to the Governor’s desk, and no one nitpicks that."
About this source
Treiber quotes Kolkhorst's challenge and argues that the attack applies a credit standard not normally applied to other legislators. He also interprets the attack as evidence of political concern about Talarico.
- Author
- André Treiber
- Published
- Accessed
Original post
Texas GOP announces Abraham George’s challenge to Talarico’s insulin-credit claim
Excerpt
"Calls on @jamestalarico to Stop Taking Credit for Republican Insulin Legislation"
About this source
The official Texas GOP account identifies Chairman Abraham George as calling on Talarico to stop taking credit for Republican insulin legislation. The caption accompanies an attached party statement.
- Author
- Republican Party of Texas / Abraham George
- Published
- Accessed
Original post
Julie Johnson disputes Kolkhorst’s allocation of insulin-cap credit
Excerpt
"He used his personal story to build massive public support for it."
About this source
Johnson responds to Kolkhorst's post, calls the attack cheap, and argues that Talarico introduced an earlier bill and generated support. Her account of why he took second billing is her attribution of motive.
- Author
- Julie Johnson
- Published
- Accessed
Original post
John Bucy III defends Talarico’s insulin-cap advocacy
Excerpt
"James' personal diabetes story is what drew the attention needed to get this passed."
About this source
Bucy quotes Kolkhorst's authorship challenge, credits Talarico's personal account and work throughout the session, and praises his ability to work across the aisle.
- Author
- John Bucy III
- Published
- Accessed
Reporting
New Talarico campaign ad puts spotlight on his role in passing bill that caps insulin costs
Relevant passage: Campaign spokesperson statement; legislative-record reporting
Excerpt
"Any assertion that he wasn’t instrumental to passing this bill is a flat-out lie."
About this source
The Texas Tribune reports a statement from Talarico campaign spokesperson JT Ennis, as well as competing accounts of the bill's development.
- Author
- Kayla Guo
- Published
- Accessed
Original text
Texas House Journal — May 24, 2021, S.B. 827 remarks
Relevant passage: PDF p. 30 (printed p. 3794), S.B. 827 — Remarks
Excerpt
"This legislation has been a team effort."
About this source
In official House-floor remarks on S.B. 827, Talarico described the effort as collaborative and thanked Lucio, Kolkhorst, and Oliverson. The journal preserves his contemporaneous characterization of roles, rather than independently resolving every participant's contribution.
- Author
- Texas House of Representatives
- Published
- Accessed
Original text
H.B. 40 — introduced bill text
Relevant passage: § 1358.058(2), introduced version
Excerpt
"Not to exceed one hundred dollars per thirty-day supply of insulin."
About this source
Talarico's introduced H.B. 40 proposed a $100 limit per 30-day supply and other provisions. It shows he advanced an earlier insulin-cap proposal, but it was not the enacted S.B. 827 text.
- Author
- Texas Legislature Online
- Accessed
Original text
S.B. 827 — House committee report bill text
Relevant passage: § 1358.103(b), House committee report version
Excerpt
"The enrollee is required to pay exceeds $25 per prescription for a 30-day supply."
About this source
The House committee report version of S.B. 827 contains the $25 cost-sharing limit enacted later. The document does not assign the revision to a particular individual.
- Author
- Texas Legislature Online
- Accessed
Original text
S.B. 827 — introduced bill text
Relevant passage: § 1358.103(b), introduced version
Excerpt
"The enrollee is required to pay exceeds $50 for a 30-day supply."
About this source
The introduced version of S.B. 827 names Kolkhorst and proposed a $50 cost-sharing limit. It establishes the bill's initial text, not who later shaped every revision.
- Author
- Texas Legislature Online
- Accessed
Original text
S.B. 827 — 87th Texas Legislature bill history
Relevant passage: 87(R) SB 827; author and sponsor fields; action history
Excerpt
"Author: Kolkhorst … Sponsor: Lucio III | Talarico."
About this source
Official legislative history identifies Lois Kolkhorst as the Senate author and Lucio III and Talarico as House sponsors. It documents formal legislative roles and passage history, rather than every participant's level of advocacy.
- Author
- Texas Legislature Online
- Accessed
Original text
S.B. 827 — enrolled Texas bill text
Relevant passage: § 1358.103(b); 30-day prescription cost-sharing cap; certification of House passage
Excerpt
"A health benefit plan may not impose a cost-sharing provision for insulin ... if the total amount the enrollee is required to pay exceeds $25 per prescription for a 30-day supply."
About this source
Enrolled text of the enacted law. It sets a $25 cost-sharing ceiling for covered health benefit plans and identifies the statutory scope; it does not assign credit among the lawmakers and advocates involved.
- Author
- Texas Legislature Online
- Accessed
Original text
H.B. 40 — 87th Texas Legislature bill history
Relevant passage: History page: filed November 9, 2020; Talarico listed among authors; left pending in House Insurance on April 6, 2021
Excerpt
"Relating to a cap on the monthly price of insulin and insulin supplies."
About this source
Official legislative history for Talarico’s H.B. 40. It establishes that he was an author of an earlier insulin-cap proposal and that the bill remained pending in committee rather than becoming the enacted $25 cost-sharing law.
- Author
- Texas Legislature Online
- Accessed
Original post
Lois Kolkhorst on authorship of Texas Senate Bill 827
Excerpt
"The truth is that you did not author the bill that passed in 2021."
About this source
Kolkhorst’s direct response to Talarico’s January 2026 insulin advertisement. She identifies herself as the filer and author of SB 827; the post addresses formal bill authorship.
- Author
- Lois Kolkhorst
- Published
- Accessed
Corrections
(1)
Corrections address errors in our reporting or labels. When a speaker changes their position, we add a separate statement and link it to the earlier one.
Reporting correction
Correction to: How much credit should James Talarico receive for Texas’s $25 insulin copay cap?
- Previous language
- PDF p. 29 (printed p. 3793), lines 1175–1187
- Corrected language
- PDF p. 30 (printed p. 3794), S.B. 827 — Remarks
The source locator for Talarico’s May 24, 2021 team-effort remarks was one page early. The remarks appear on PDF page 30, printed page 3794. The quotation and event date are unchanged.
This corrects our account of what happened.
In official House-floor remarks on S.B. 827, Talarico described the effort as collaborative and thanked Lucio, Kolkhorst, and Oliverson. The journal preserves his contemporaneous characterization of roles, rather than independently resolving every participant's contribution.
Share or embed this case
The embed keeps its attribution link to The Dispute Index. Credit the image to The Dispute Index and link to the case page.
Cite this record
- Publisher
- The Dispute Index
- Title
- How much credit should James Talarico receive for Texas’s $25 insulin copay cap?
- First published
- Last updated
- Permalink
- https://disputeindex.com/cases/james-talarico-texas-25-dollar-insulin-copay-cap-credit
The Dispute Index. "How much credit should James Talarico receive for Texas’s $25 insulin copay cap?". First published: 2026-09-14. Last updated: 2026-09-15. https://disputeindex.com/cases/james-talarico-texas-25-dollar-insulin-copay-cap-credit